All Exams Test series for 1 year @ ₹349 only
Question

Calcium resonium, which is used to treat hyperkalaemia over a short-term in chronic kidney disease, is associated with the development of which one of the following conditions?

This question was previously asked in
UPSC CMS 2026 Surgery, Gynaecology & Obstetrics, and PSM Question Paper (02-Aug-2026)
The correct answer is

Bowel Necrosis

Calcium resonium (a calcium/sodium polystyrene sulfonate cation-exchange resin) used for hyperkalaemia has been associated with intestinal/colonic necrosis, particularly when co-administered with sorbitol, making bowel necrosis a well-recognised serious adverse effect.

Was this answer helpful?

Similar Questions

  1. Sodium zirconium cyclosilicate and patiromer are commonly prescribed to chronic kidney disease patients because of their property of binding to which one of the following electrolytes?

  2. Deficiency of which of the following mineral(s) can lead to hypocalcemia by impairing the ability of the parathyroid gland to secrete parathyroid hormone?

    1. Phosphate

    2. Magnesium

    3. Sodium

    4. Potassium

    Select the correct answer using the code given below:


Important Questions from Electrolyte Imbalance

  1. Which of the following does NOT cause prolongation of QT interval?
  2. Which of the following does NOT causes polyuria?
  3. A 36-year old chronic alcoholic, malnourished male is hospitalized with pneumonia. His condition worsens after aggressive treatment with intravenous dextrose and antibiotics. This phenomenon of 'Refeeding Syndrome' is accompanied by which one of the following biochemical alterations?
  4. Which one of the following drugs causes hypercalcemia?
  5. Syndrome of Inappropriate ADH secretion (SIADH) is usually associated with:
Need Expert Advice?

Start Your Preparation with Prepp Mobile App

Download the app from Google Play & App Store
Download the app from Google Play & App Store
Prepp Mobile App